GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Price-to-Operating-Cash-Flow

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Price-to-Operating-Cash-Flow : (As of Jun. 08, 2024)


View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Price-to-Operating-Cash-Flow?

As of today (2024-06-08), Pathfinder Cell Therapy's share price is $0.0001. Pathfinder Cell Therapy's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2015 was $0.00. Hence, Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow or its related term are showing as below:

PFND's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.29
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Pathfinder Cell Therapy's Cash Flow from Operations per share for the three months ended in Sep. 2015 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2015 was $0.00.


Pathfinder Cell Therapy Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Price-to-Operating-Cash-Flow Chart

Pathfinder Cell Therapy Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pathfinder Cell Therapy Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow falls into.



Pathfinder Cell Therapy Price-to-Operating-Cash-Flow Calculation

Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.0001/0
=

Pathfinder Cell Therapy's Share Price of today is $0.0001.
Pathfinder Cell Therapy's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Pathfinder Cell Therapy Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Traded in Other Exchanges
N/A
Address
12 Bow Street, Cambridge, MA, USA, 02138
Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.
Executives
John J Alam director 130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks director 100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines